1. Home
  2. ZURA vs SKLZ Comparison

ZURA vs SKLZ Comparison

Compare ZURA & SKLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • SKLZ
  • Stock Information
  • Founded
  • ZURA 2022
  • SKLZ 2012
  • Country
  • ZURA United States
  • SKLZ United States
  • Employees
  • ZURA N/A
  • SKLZ N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • SKLZ EDP Services
  • Sector
  • ZURA Health Care
  • SKLZ Technology
  • Exchange
  • ZURA Nasdaq
  • SKLZ Nasdaq
  • Market Cap
  • ZURA 137.2M
  • SKLZ 123.9M
  • IPO Year
  • ZURA N/A
  • SKLZ N/A
  • Fundamental
  • Price
  • ZURA $3.34
  • SKLZ $7.12
  • Analyst Decision
  • ZURA Buy
  • SKLZ Buy
  • Analyst Count
  • ZURA 9
  • SKLZ 1
  • Target Price
  • ZURA $11.00
  • SKLZ $14.00
  • AVG Volume (30 Days)
  • ZURA 4.3M
  • SKLZ 66.6K
  • Earning Date
  • ZURA 11-06-2025
  • SKLZ 11-06-2025
  • Dividend Yield
  • ZURA N/A
  • SKLZ N/A
  • EPS Growth
  • ZURA N/A
  • SKLZ N/A
  • EPS
  • ZURA N/A
  • SKLZ N/A
  • Revenue
  • ZURA N/A
  • SKLZ $93,320,000.00
  • Revenue This Year
  • ZURA N/A
  • SKLZ $17.44
  • Revenue Next Year
  • ZURA N/A
  • SKLZ $12.03
  • P/E Ratio
  • ZURA N/A
  • SKLZ N/A
  • Revenue Growth
  • ZURA N/A
  • SKLZ N/A
  • 52 Week Low
  • ZURA $0.97
  • SKLZ $3.54
  • 52 Week High
  • ZURA $4.96
  • SKLZ $9.11
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 55.62
  • SKLZ 42.26
  • Support Level
  • ZURA $3.18
  • SKLZ $7.13
  • Resistance Level
  • ZURA $3.51
  • SKLZ $7.46
  • Average True Range (ATR)
  • ZURA 0.36
  • SKLZ 0.32
  • MACD
  • ZURA -0.08
  • SKLZ -0.08
  • Stochastic Oscillator
  • ZURA 50.40
  • SKLZ 32.08

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About SKLZ Skillz Inc.

Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.

Share on Social Networks: